Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
J Acquir Immune Defic Syndr ; 93(2): 101-106, 2023 06 01.
Artículo en Inglés | MEDLINE | ID: mdl-36881836

RESUMEN

INTRODUCTION: In 2020, an estimated 150,000 infants acquired HIV infection through vertical transmission. With pregnant and breastfeeding women facing numerous social and health system barriers, continuity of care for mother-infant pairs (MIPs) requires prioritized engagement for timely infant HIV testing and linkage to treatment. METHODS: PEPFAR Monitoring, Evaluation, and Reporting indicators were analyzed from across 14 USAID-supported countries across 3 fiscal years (FYs) (October 2018-September 2021): number of HIV-exposed infants (HEIs) with a sample collected for an HIV test by age 2 months, percentage of HEI who received an HIV test by age 2 months (EID 2 mo coverage), and final outcome status of HEIs. Qualitative information on implementation of PVT interventions was gathered using a structured survey disseminated to USAID/PEPFAR country teams. RESULTS: From October 2018 to September 2021, 716,383 samples were collected for infant HIV tests. EID 2 mo coverage increased across the FYs from 77.3% in FY19% to 83.5% in FY21. Eswatini, Lesotho, and South Africa demonstrated the highest EID 2 mo coverage across all 3 FYs. Burundi (93.6%), DRC (92%), and Nigeria (90%) had the highest percentage of infants with a known final HIV outcome. Qualitative survey data showed that the most implemented interventions used by the countries were mentor mothers, appointment reminders, cohort registers, and joint provision of MIP services. CONCLUSIONS: Achieving eVT requires a client-centered and multipronged approach, typically combining several PVT interventions. Country and program implementers should use person-centered solutions to best target MIPs to be retained in the continuum of care.


Asunto(s)
Infecciones por VIH , Complicaciones Infecciosas del Embarazo , Lactante , Embarazo , Humanos , Femenino , Infecciones por VIH/diagnóstico , Infecciones por VIH/prevención & control , Madres , Lactancia Materna , Nigeria , Transmisión Vertical de Enfermedad Infecciosa/prevención & control , Diagnóstico Precoz , Complicaciones Infecciosas del Embarazo/prevención & control
2.
J Acquir Immune Defic Syndr ; 88(2): 165-172, 2021 10 01.
Artículo en Inglés | MEDLINE | ID: mdl-34506359

RESUMEN

BACKGROUND: Despite their disparately high HIV incidence and voiced willingness to use pre-exposure prophylaxis (PrEP), Black cisgender women's knowledge and uptake of PrEP are low, especially relative to White cisgender women and men who have sex with men. Mounting evidence demonstrates that health care provider recommendations are a critical factor in women's awareness, willingness, and ability to uptake PrEP. Health care providers may make clinical judgments about who is (not) a good candidate for PrEP based on unconscious and conscious stereotypes and prejudice. SETTING: We conducted an online experiment among N = 160 health care providers with prescribing privileges in the 48 HIV hotspot counties. METHOD: Providers received 1 of 4 vignettes about a PrEP eligible woman. Vignettes varied by patient race and substance use status. Then, providers reported their willingness to discuss PrEP with the patient and willingness to prescribe PrEP to her. RESULTS: We tested 2 models predicting providers (1) willingness to discuss and (2) willingness to prescribe PrEP, contingent on their racial attitudes. Providers who scored high on a modern racism measure were less willing to discuss and prescribe PrEP to the Black patient. These effects were mediated by provider perceptions of patients' abilities to adhere to PrEP, but not their expectations of risk compensatory behaviors. CONCLUSIONS: Our findings highlight the importance of applying an intersectional lens in documenting the processes that exacerbate inequities in PrEP use. This study provides evidence to support the development of interventions that address the mechanisms that work to thwart optimal care.


Asunto(s)
Fármacos Anti-VIH/administración & dosificación , Actitud del Personal de Salud , Prescripciones de Medicamentos/estadística & datos numéricos , Infecciones por VIH/prevención & control , Personal de Salud/psicología , Disparidades en Atención de Salud , Profilaxis Pre-Exposición/métodos , Adulto , Fármacos Anti-VIH/uso terapéutico , Sesgo , Femenino , Infecciones por VIH/etnología , Infecciones por VIH/psicología , Encuestas de Atención de la Salud , Conocimientos, Actitudes y Práctica en Salud , Accesibilidad a los Servicios de Salud , Homosexualidad Masculina , Humanos , Masculino , Profilaxis Pre-Exposición/estadística & datos numéricos , Prejuicio , Atención Primaria de Salud , Racismo , Factores Socioeconómicos , Encuestas y Cuestionarios
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...